Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD

Autores de IIS La Fe

• Elvira Mora Castera

  Autor

• Pedro Asensi Cantó

  Autor

• Guillermo Sanz Santillana

  Autor

Participantes ajenos a IIS La Fe

• Vilorio-Marqués L.
• Castañón Fernández C.
• Gutiérrez L.
• Rey Bua B.
• Jiménez Lorenzo M.J.
• Díaz Beya M.
• Vara Pampliega M.
• Molero A.
• Sánchez-García J.
• Calabuig M.
• Cedena M.T.
• Chen-Liang T.
• Díaz Santa J.A.
• Padilla I.
• Hernández F.
• Díez R.
• Xicoy B.
• Valcárcel D.
• Diez-Campelo M.
• Bernal T.

Grupos

• Hematología y Hemoterapia

Abstract

Abstract no disponible

Keywords

• azacitidine; fluconazole; hemoglobin; itraconazole; posaconazole; quinolone derivative; voriconazole; acute myeloid leukemia; aged; Article; cancer patient; chronic myelomonocytic leukemia; cohort analysis; cytogenetics; disease severity; female; follow up; hospitalization; human; infection rate; leukocyte count; lymphocyte count; male; mortality; myelodysplastic syndrome; myelofibrosis; neutrophil count; observational study; outcome assessment; overall survival; platelet count; prophylaxis; retrospective study; thrombocytopenia; treatment outcome